A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variants.
Meyer-Schuman R, Cale AR, Pierluissi JA, Jonatzke KE, Park YN, Lenk GM, Oprescu SN, Grachtchouk MA, Dlugosz AA, Beg AA, et al. HGG Adv. 2024 Jul 18; 5(3):100324. Epub 2024 Jul 2.